These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14898200)

  • 21. Clinical evaluation of 1-(beta-dimethylaminoethoxy)-3-n-butylisoquinoline monohydrochloride as an antipruritic agent.
    CALLAWAY JL; WATKINS WT; CRANE GW; DEES SC
    N C Med J; 1951 Nov; 12(11):546-8. PubMed ID: 14882650
    [No Abstract]   [Full Text] [Related]  

  • 22. Antipruritic qualities of papaverine hydrochloride.
    WIRTH L
    J Invest Dermatol; 1947 Feb; 8(2):63. PubMed ID: 20286532
    [No Abstract]   [Full Text] [Related]  

  • 23. Trimerazine ("vallergan"): its assessment as an antipruritic.
    TAFT EH; ENTWISLE BR; LANGLEY R
    Med J Aust; 1960 Aug; 47(2)():208-10. PubMed ID: 13836572
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical experiences with a new antipruritic drug].
    BOHM C
    Arch Klin Exp Dermatol; 1955; 200():336-41. PubMed ID: 13249425
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical evaluation of antipruritic drugs; consideration of orally or parenterally administered agents.
    CORMIA FE; DOUGHERTY JW
    AMA Arch Derm; 1959 Feb; 79(2):172-8. PubMed ID: 13616714
    [No Abstract]   [Full Text] [Related]  

  • 26. Double-blind evaluation of trimeprazine, an oral antipruritic.
    LONDON ID
    AMA Arch Derm; 1959 Aug; 80(2):220-1. PubMed ID: 13669750
    [No Abstract]   [Full Text] [Related]  

  • 27. Aminophylline as an antipruritic agent; comparison with certain other theophylline salts.
    EPSTEIN E
    Arch Derm Syphilol; 1948 Jul; 58(1):47-51. PubMed ID: 18110532
    [No Abstract]   [Full Text] [Related]  

  • 28. Aminophylline as an antipruritic agent; comparison with tetraethylammonium chloride.
    EPSTEIN E
    Urol Cutaneous Rev; 1949 Oct; 53(10):627. PubMed ID: 18141449
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of itching; a preliminary report on results with a new oral antipruritic.
    LINCOLN CS; NORDSTROM RC; BATTS EE
    Calif Med; 1959 Feb; 90(2):126-7. PubMed ID: 13629347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of chronic pruritus-what is new?].
    Zeidler C; Metz M; Steinke S; Ständer S
    Hautarzt; 2018 Aug; 69(8):641-646. PubMed ID: 29931387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pruritus in connective tissue and other common systemic disease states.
    Galatian A; Stearns G; Grau R
    Cutis; 2009 Oct; 84(4):207-14. PubMed ID: 19911676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical antihistamine therapy in pruritus of the ano-genital region.
    FINKLER RS
    Urol Cutaneous Rev; 1952 Feb; 56(2):83-5. PubMed ID: 14913826
    [No Abstract]   [Full Text] [Related]  

  • 33. [EXPERIENCES WITH THE ANTIHISTAMINIC DRUG FENISTIL AS AN ANTIPRURITIC AGENT AND AS A COMMERCIAL DRUG].
    DECHANT R
    Munch Med Wochenschr; 1964 Jun; 106():1187-8. PubMed ID: 14234256
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of topical antipruritic therapy on experimentally induced pruritus in man.
    MELTON FM; SHELLEY WB
    J Invest Dermatol; 1950 Oct; 15(4):325-32. PubMed ID: 14779048
    [No Abstract]   [Full Text] [Related]  

  • 35. Measurement of the effect of topical antipruritic agents on experimentally induced pruritus.
    MACRIS SG; BLANK IH; BEECHER HK
    J Invest Dermatol; 1959 Jul; 33(1):15-8. PubMed ID: 13673206
    [No Abstract]   [Full Text] [Related]  

  • 36. [TOPICAL TREATMENT OF DERMATOSES WITH A NEW ANTIPRURITIC AGENT IN CLINICAL PRACTICE].
    WIFLING L; GRAATZ H
    Hippokrates; 1964 Jul; 35():528-30. PubMed ID: 14249305
    [No Abstract]   [Full Text] [Related]  

  • 37. [Penetrasol-benedryl as local antipruritic].
    TELLO EE
    Rev Med Cordoba; 1950 Sep; 38(9):402-4. PubMed ID: 14786795
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pruritus in pregnancy. A frequent diagnostic and therapeutic challenge].
    Weisshaar E; Witteler R; Diepgen TL; Luger TA; Ständer S
    Hautarzt; 2005 Jan; 56(1):48-57. PubMed ID: 15536515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An experimental method for screening antipruritic agents.
    JOGLEKAR GV; BHIDE MB; BALWANI JH
    Br J Dermatol; 1963 Mar; 75():117-9. PubMed ID: 13957807
    [No Abstract]   [Full Text] [Related]  

  • 40. Neurologic Itch Management.
    Şavk E
    Curr Probl Dermatol; 2016; 50():116-23. PubMed ID: 27578080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.